Amgen

RIABNI

View Prices
  1. Home
    2.  / 
  2. Q Code
    3.  / RIABNI – Q5123

Manufacturer:

Amgen

Name:

RIABNI

HCPCS Code Descriptor:

Injection, rituximab-arrx, biosimilar, (riabni), 10 mg

Category:

Q Code

HCPCS:

Q5123

NDC(s):

55513-0326-01, 55513-0224-01

Primary Type:

Oncology Biosimilar

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

RIABNI is an Oncology Biosimilar drug manufactured by Amgen and administered via the Intravenous route of administration. The Q Code: Q5123 is aligned to the drug RIABNI.

Riabni is a biosimilar for the reference drug Avastin (J9035)

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/21

HCPCS Effective Date:

7/1/21

HCPCS Short Description:

Inj. riabni, 10 mg

Billing and Coding Guide:

https://www.riabni.com/oncology/-/media/Themes/Amgen/riabni/Riabni/PDF/RIABNI-Product-Resource-Guide

Patient Assistance:

https://www.amgenassist.com/copay

http://www.amgensafetynetfoundation.com